Investor Communications

8 July 2020

Instem plc
(“Instem” or the “Company”)

Investor Communications

Instem plc (AIM: INS), a leading provider of IT solutions to the global life sciences market, announces that the Company intends to host a live presentation via the Investor Meet Company platform in the coming weeks. A date and time will be announced in due course. Investors can sign up to Investor Meet Company for free via https://investormeetcompany.com/instem-plc/register-investor and add to meet Instem.

For further information, please contact:

Instem plc	www.instem.com
Phil Reason, CEO	Via Walbrook
Nigel Goldsmith, CFO
N+1 Singer (Nominated Adviser & Broker)	+44 (0) 20 7496 3000
Peter Steel (Corporate Finance)
Rachel Hayes (Corporate Broking)
Wallbrook Financial PR	Tel: +44 (0) 20 7933 8780
Tom Cooper
Nick Rome

About Instem

Instem is a leading provider of IT solutions & services to the life sciences market delivering compelling solutions for Study Management and Data Collection; Regulatory Solutions for Submissions and Compliance; and Informatics-based Insight Generation.

Instem solutions are in use by over 500 customers worldwide, including all the largest 25 pharmaceutical companies, enabling clients to bring life enhancing products to market faster. Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonisation of actionable scientific information.

Instem products and services address aspects of the entire drug development value chain, from discovery through to market launch. Management estimate that over 50% of all drugs on the market have been through some part of Instem's platform at some stage of their development.

To learn more about Instem solutions and its mission, please visit instem.com.